Document Type : Original Article
Department of Medical Laboratory Science, College of Medicals and Applied Sciences, Charmo University, Chamchamal, Sulaimani, Kurdistan Region, Iraq
Threats of Acinetobacter baumannii, a Gram-negative and multi-drug resistant bacterium,to the public health have recently received great attention worldwide. This is because the high incidence rate of the bacterial infections and the ability of the A. baumannii to resist a wide range of antibiotics. This study is designed to investigate the antimicrobial activity of the cinnamon oil in water as Nano emulsions (NEs) alone and in combination with different antibiotics against clinical isolate of A. baumannii. At the beginning, the minimum inhibitory concentration (MIC) of different antibiotics and also cinnamon Nano emulsions (CNEs) are determined. Later, the synergistic effect of the CNEs with each of the studied antibiotics is also examined. Results showed that the bacterium has the highest resistant towards ampicillin (MIC = 700 µg/ml), followed by kanamycin, and gentamycin with MIC of each of the antibiotics was 200µg/ml and 150 µg/ml, respectively. Cinnamon Nano emulsions (CNEs) were also showed a profound inhibitory effect on A. baummanii. Interestingly, combinations of cinnamon Nano emulsions (CNEs) with either kanamycin or gentamycin, but not ampicillin, show a significant increase in the antimicrobial activity of each of the antibiotics compared to when they were used alone. The results of this study strongly suggest the potential application of CNEs in combination with antibiotics to overcome A. baummanii infections.
Acinetobacter baumannii is an important multi-drug resistant (MRD), Gram-negative opportunistic pathogen that causes a number of serious health issues, including pneumonia, bloodstream, urinary tract, and wound infections in hospitalized patients (1,2). Recent reports on A. baumannii infections alarmed that this pathogen rapidly increased worldwide and serious concern has been paid to minimize the incidence of this pathogen (3). There are also several reports on isolating of A. baumannii among those casualties who were hospitalized in Iraq during Iraqi freedom operation (4-6). For this reason researchers named this pathogen as “Iraqi bacter” (7,8). In its annual report of 2017, World Health Organization (WHO) also categorized A. baumannii asnumber one priority pathogen to be tackled through developing new therapeutic agents (9).
Nano emulsions (NEs) are clear emulsified mixtures of particles (average droplet range in size from 50-800 nm) that are made up of water, oil, a surfactant (e.g. Tween 80 and Capriole 90), which is a surface tension reducing agent, and sometimes a co-surfactant (e.g. Propanol and ethanol), which makes a surfactant more effective and enhances its abilities (6,10).
Currently, researchers mainly focused on using different plant-based oil extracts to prepare NEs due to its bioavailability and biocompatibility (11). NEs have many applications in the pharmaceutical and food industry; they can work as good delivery systems for both hydrophobic and hydrophilic drugs and also as solvents for other non-water soluble drugs (10,12). In addition, they can easily manufactured and have a stable thermodynamic property (10,12). As a drug delivery tool, nanoparticles fuse with the lipid-containing plasma membrane of the organism and its potential energy is released from the interactions of the NEs cations and the anions from the cell membrane of the pathogen. This, eventually causes degeneration of the plasma membrane of the pathogen and death (13).
Cinnamon (Cinnamomum zeylanicum) has been used for centuries by human as a spice and flavouring agent for cooking and also as medicine (14). The antibacterial activity of cinnamon essential oil exhibited strong antibacterial activities against different clinical isolates of Escherichia coli and Staphylococcus aureus (15,16). This study has aimed to investigate the antibacterial activity of CNEs against A. baummannii strain H72721 and to determine its synergistic effect, when combined with other antibiotics which were used in the study.
2. Materials and Methods
Tween 80, Tryptic Soy Broth (TSB) and antibiotics were all obtained from Sigma-Aldrich- US. Water was taken from Milli-Q-water purification system (Millipore, MA, USA).
2.2 Bacterial strain
Acinetobacter baumanii strain (H72721) was purchased from American Type Culture Collection (ATCC) beiresources (catalog No. NR-9667).
2.3 Preparation of the Nanoemulsion
Cinnamon Nano emulsions (CNEs) were prepared by mixing locally purchased cinnamon essential oil, deionized water, and 5% tween 80 as a surfactant using high energy method ultrasonicator for 20 minutes until a homogenous suspension was formed. Then, the droplet size was measured by using transmission electron microscopy (TEM) following Gosh et al. 2013 (17).
2.4 Determination of minimal inhibitory concentration (MIC)
The antibiotic susceptibility test was carried out as previously described (18). Briefly, the A. baumanii strain H72721was grown in 50 ml TSB medium with shaking at 30°C. When OD600 reached 0.6, aliquot of the culture was diluted with TSB to OD600 ~ 0.1 to be used for antibiotic sensitivity test. Twenty microliters (20 µl) of the diluted culture was mixed with 160 µl of Tryptic Soy Broth (TSB) and 20 µl of the serial dilutions from each of these antibiotics (ampicillin, kanamycin and gentamycin) or CNEs in a 96 polystyrene micro well plates. The concentration ranged from 7 mg to 1 mg of the each of the antibiotic stocks which were used in the experiment followed by10 folds dilution of the antibiotic upon the addition to the well. The microplate was incubated for 20 hours at 30 °C and the optical density was measured at 600 nm by a microplate reader.
2.5 Nanoemulsion-Antibiotic synergistic experiment
The synergistic effect of the antibiotics was tested separately with and without adding 0.05% CNEs in a 96-well plate. The bacterial cells were grown in TSB medium as mentioned above. Then, 20 µl of the culture (OD 600 ~ 0.1) is added to each of the wells containing 160 µl of the medium with 20 µl of 0.05% of CNEs and an antibiotic. The final concentrations of each of the tested antibiotics in the well were 300 µg/ml of ampicillin, 25 µg/ml of kanamycin and gentamycin. The microplates were incubated for 20 hours at 30°C. Finally, the growth of the bacterial cells was measured by a microplate reader in the optical density (OD600).
3. Results and Discussion
Massive production, uncontrolled consumption and random prescription of antibiotics have led to the emergence of several genera of multi-drug resistant (MDR) bacteria, which are now a serious challenge to the global public health. A. baumannii is among the MDR bacteria that the treatment of their infections has become increasingly problematic because of their resistance to multiple classes of antibiotics (3). Thus, this study is conducted to test the antibacterial activity of cinnamon Nano emulsions (CNEs) and its synergistic action with some antibiotics on a MRD strain of A. baummannii H72721. In the beginning, the minimum inhibitory concentrations (MIC) of ampicillin, kanamycin, and gentamycin were determined against A. baummannii H72721. The MICs for ampicillin, kanamycin, and gentamycin were found to be 700 µg/ml, 200µg ml-1, and 150 µg ml-1 respectively (Figure 1 and 2).
Figure 1: MIC of kanamycin and ampicillin against A. baumannii. Growth of A. baumannii in TSB 20 hours after incubation at 30 ֯C without any antimicrobial agent and with different concentration of ampicillin and kanamycin. Data shown are the means of data from three replicates ± standard deviations.
The high degree of the bacterial resistance towards ampicillin and less towards kanamycin and gentamycin can be due to the differences in the antibiotic's mode of action. The bactericidal effect of ampicillin occurs as the result of its inhibitory action on the cell wall synthesis of the bacteria (19). However, kanamycin and gentamycin exhibit antimicrobial activity by inhibiting bacterial translation process through binding to the 16S rRNA component of the 30S RNA (20). The more consumption and frequent prescription of ampicillin in the clinical settings can also be another factor that bacteria are generally more resistant to ampicillin.
In order to measure the antimicrobial activity of the CNEs, a mixture of cinnamon oil, water and tween 80 was prepared. The average particles size and the percentage of polydispersity of the CNEs were found as 9.35±2.5 nm and 25.73±5 nm, respectively. The antimicrobial property of the CNEs and also their MIC were examined by having 0% (positive control) to 0.15% of NEs in the bacterial culture. The total bacterial growth was inhibited at the present of 0.09% of NEs in the culture (Figure 3).
Figure 2: MIC of gentamycin against A. baumannii. Growth of A. baumannii in TSB 20 hours after incubation at 30 ֯C without any antimicrobial agent and with different concentration of the gentamycin. Data shown are means of data from three replicates ± standard deviations.
Figure 3: Effect of different concentration of cinnamon nanoemulsion on the growth of A. baumanni. Data shown are means of data from three replicates ± standard deviations.
The antibacterial activity of cinnamon essential oil is already reported on different bacterial species (15,16). In the present study, the antimicrobial activity of the cinnamon essential oil was tremendously increased when it was used in the form of CNEs. This result suggests that A. baumannii is very sensitive to cinnamon and this is probably due to the dual actions of both the emulsion and the cinnamon oil constituents on bacterial cells. This can be supported by the ability of NE particles to incorporate into the phospholipid bilayers of the cell membrane. This is followed by destabilizing of the plasma membrane and finally leading to the bacterial cell death (13). Moreover, the antibacterial activity of cinnamon is ascribed to its bioactive phytochemical constituents such as cinnamaldehyde and eugenol (21). However, the precise action mechanism of cinnamon constituents on bacterial cells has been left unclear.
Combinations of different antibiotics, such as ampicillin and cloxacillin, are used since a long time to overcome resistant bacteria (22). The penicillinase inhibitor, clavulanic acid, is mixed with amoxicillin to treat infections that are caused by penicillinase-producing bacteria (23). Same approach is taken in this study in order to show the synergistic action of CNEs and the studied antibiotics.
Interestingly, the antimicrobial activity of both kanamycin and gentamycin were significantly increased to 72% and 22% respectively when they were combined with CNEs (Figure 4). However, there was not a significant different in the antimicrobial activity of ampicillin when it was combined with CNEs in the experimental setup (Figure 4).
Figure 4: Growth of A. baumannii after exposure to 0.04% of cinnamon Nano emulsions alone and with different concentration of different antibiotics. The antibiotics that were used are ampicillin (300 µg/ml), kanamycin (25 µg/ml), and gentamycin (25 µg/ml). Data shown are means of data from three replicates ± standard deviations.
The improvement of the antimicrobial activity of both kanamycin and gentamycin can be due to the dual actions of both CNEs and antibiotics together. In this situation, the simultaneous impairment of the plasma membrane permeability by the CNEs (13) and inhibition of protein synthesis by both the antibiotics occurred in the bacterial cells (20). The fact of not having an increase in the antibiotic activity of ampicillin when it was combined with CNEs could be due to the ampicillin's mode of action and its bactericidal activity. This means that ampicillin first killed the cells through cell wall disruption and followed by osmolysis (19), so the effect of the CNEs cannot be observed on already dead cells.
In conclusion, the results that the current study has come across suggest a significant increase in the antibacterial activity of both kanamycin and gentamycin when they are used in combination with CNEs. Thus, such combination could be used to tackle multi-drug resistant A. baummannii particularly in topical treatments.
The authors are thankful to the reviewers of the manuscript, and their constructive comments are gratefully acknowledged.
Conflict of interest
- Alsan, M., and Klompas, M. (2010) Acinetobacter baumannii: An Emerging and Important Pathogen. Journal of clinical outcomes management : JCOM 17, 363-369
- Urban, C., Segal-Maurer, S., and Rahal, J. J. (2003) Considerations in Control and Treatment of Nosocomial Infections Due to Multidrug-Resistant Acinetobacter baumannii. Clinical Infectious Diseases 36, 1268-1274
- Harding, C. M., Hennon, S. W., and Feldman, M. F. (2018) Uncovering the mechanisms of Acinetobacter baumannii virulence. Nature Reviews Microbiology 16, 91
- Centers for Disease Control and Prevention (CDC. (2004) Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR. Morbidity and mortality weekly report 53, 1063-1066
- Davis, K. A., Moran, K. A., McAllister, C. K., and Gray, P. J. (2005) Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers. Emerging Infectious Diseases 11, 1218-1224
- Hwang, Y. Y., Ramalingam, K., Bienek, D. R., Lee, V., You, T., and Alvarez, R. (2013) Antimicrobial Activity of Nanoemulsion in Combination with Cetylpyridinium Chloride in Multidrug-Resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 57, 3568-3575
- Howard, A., O''''Donoghue, M., Feeney, A., and Sleator, R. D. (2012) Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence 3, 243-250
- Turton, J. F., Kaufmann, M. E., Gill, M. J., Pike, R., Scott, P. T., Fishbain, J., Craft, D., Deye, G., Riddell, S., Lindler, L. E., and Pitt, T. L. (2006) Comparison of Acinetobacter baumannii Isolates from the United Kingdom and the United States That Were Associated with Repatriated Casualties of the Iraq Conflict. Journal of Clinical Microbiology 44, 2630-2634
- WHO. (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Geneva: World Health Organization
- Sowjanya, G., and Bandhavi, P. (2012) Nanoemulsions an emerging trend: a review. IJPRD 4, 137-152
- Saranya, S., Chandrasekaran, N., and Mukherjee, A. (2012) Antibacterial activity of eucalyptus oil nanoemulsion against Proteus mirabilis. Int J Pharm Pharm Sci 4, 668-671
- Sharma, N., Mishra, S., Sharma, S., Deshpande, R. D., and Sharma, R. K. (2013) Preparation and optimization of nanoemulsions for targeting drug delivery. Int. J. Drug Dev. & Res 5, 37-48
- Jaiswal, M., Dudhe, R., and Sharma, P. K. (2015) Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech 5, 123-127
- Rao, P. V., and Gan, S. H. (2014) Cinnamon: A Multifaceted Medicinal Plant. Evidence-Based Complementary and Alternative Medicine 2014, 12
- Zhang, Y., Liu, X., Wang, Y., Jiang, P., and Quek, S. (2016) Antibacterial activity and mechanism of cinnamon essential oil against Escherichia coli and Staphylococcus aureus. Food Control 59, 282-289
- Urbaniak, A., Glowacka, A., Kowalczyk, E., Lysakowska, M., and Sienkiewicz, M. (2014) [The antibacterial activity of cinnamon oil on the selected gram-positive and gram-negative bacteria]. Medycyna doswiadczalna i mikrobiologia 66, 131-141
- Ghosh, V., Saranya, S., Mukherjee, A., and Chandrasekaran, N. (2013) Cinnamon oil nanoemulsion formulation by ultrasonic emulsification: investigation of its bactericidal activity. Journal of nanoscience and nanotechnology 13, 114-122
- Sabir, D. (2018) Synergistic Effect of Silver Nanoparticles Combined with Different Antibiotics against Multidrug-Resistant Acinetobacter Baumannii Strain H72721. ICNS Conference Proceeding), 7-11
- Chudobova, D., Dostalova, S., Blazkova, I., Michalek, P., Ruttkay-Nedecky, B., Sklenar, M., Nejdl, L., Kudr, J., Gumulec, J., Tmejova, K., Konecna, M., Vaculovicova, M., Hynek, D., Masarik, M., Kynicky, J., Kizek, R., and Adam, V. (2014) Effect of Ampicillin, Streptomycin, Penicillin and Tetracycline on Metal Resistant and Non-Resistant Staphylococcus aureus. International Journal of Environmental Research and Public Health 11, 3233-3255
- Kohanski, M. A., Dwyer, D. J., and Collins, J. J. (2010) How antibiotics kill bacteria: from targets to networks. Nature reviews. Microbiology 8, 423-435
- Vijayan, K., and Thampuran, R. A. (2004) 11 Pharmacology and Toxicology of Cinnamon and Cassia. Cinnamon and cassia: the genus Cinnamomum 259
- Bornside, G. H. (1968) Synergistic antibacterial activity of ampicillin-cloxacillin mixtures against Proteus morganii. Applied microbiology 16, 1507-1511
- Yogev, R., Melick, C., and Kabat, W. J. (1981) In vitro and in vivo synergism between amoxicillin and clavulanic acid against ampicillin-resistant Haemophilus influenzae type b. Antimicrob Agents Chemother 19, 993-996